No other insider has filed at Richard I. Steinhart's companies, so these are insiders reporting open-market trades at other companies in the same sector.
AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
Richard I. Steinhart is a corporate insider, tracked as Director of Actinium Pharmaceuticals, Inc. (ATNM). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard I. Steinhart submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Richard I. Steinhart been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($12K) across all tracked filings.
Richard I. Steinhart is Director of Actinium Pharmaceuticals, Inc. (ATNM). 15 SEC Form 4 filings on record going back to 2024, most recently on 4 September 2026. Most recent open-market trade: sold $7K of BTAI on 22 May 2026. Lifetime open-market sales: $12K.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Richard I. Steinhart.
InsiderAlpha's records for Richard I. Steinhart go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. 11 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
